Long-term follow-up of Lumen-Apposing Metal Stent (LAMS) in benign pathology
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S574
DOI: 10.1055/s-0046-1821719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von C Pérez Urra und 16 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Luminal apposing stents are used to treat digestive tract stenosis with better results than endoscopic dilation and with a better morbidity and mortality profile than surgery. Despite an increase in their use, there is no evidence regarding their long-term safety. Below is a series of patients who have had LAMS for more than twelve months at our center [ 1 ] [ 2 ].
Methods
Observational, descriptive, and retrospective study of patients with LAMS for more than one year due to benign digestive pathology.
Results
The sample consisted of five patients with a mean age of 68.8 years (SD: 25.23) and 60% males. The indication in all cases was benign stenosis: three duodenal stenoses (two secondary to chronic pancreatitis and the third post-ulcerative) in which gastroenteroanastomosis was performed, one peptic pyloric stenosis in which a transpyloric LAMS was placed, and one gastrointestinal anastomotic stenosis in which a prosthesis was used in the anastomosis. The most commonly used Hot-Axios prosthesis (60%) had a diameter of 10x10 mm; in both cases indicated for duodenal stenosis secondary to chronic pancreatitis, it presented as a complication of obstruction at 17 and 23 months, requiring replacement with a 20x10 stent, and in the third case, used for pyloric stenosis, it was removed at 17 months due to restenosis and requiring reinsertion. In post-ulcer duodenal stenosis, a 15x10 diameter was used and after 13 months of follow-up, no complications have been reported. Finally, in gastrointestinal anastomotic stenosis, a 20x10 Hot-Axios was used without incident after 26 months of follow-up.
Conclusions
The placement of LAMS in benign stenoses has revolutionized the management of many digestive pathologies with good results and an acceptable complication rate, allowing other more aggressive therapies such as surgery to be avoided. In our experience with long-term prostheses, there were no serious complications, with prosthesis obstruction in those with a smaller diameter being the most frequent adverse effect (40%). Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Urra, C. P., Pinedo, P. E., Labrador, C. B. B., Ibañez, C. M., Moretón, Á. M., Castro, E. G. D., Citores, L. P., Antolín, S. M., Rodríguez, M. A. R., Osa, D. R. D. L., Silva, B. A. M. D., Román, M. C., Santamarta, F. S., Fernández, J. S., Laguna, J. B., Medina, F. J. R., & Millán, A. G. P. (2026). Long-term follow-up of Lumen-Apposing Metal Stent (LAMS) in benign pathology. Endoscopy, 58(S 03 S 03), S574. https://doi.org/10.1055/s-0046-1821719
Vancouver
Urra CP, Pinedo PE, Labrador CBB, Ibañez CM, Moretón ÁM, Castro EGD, et al. Long-term follow-up of Lumen-Apposing Metal Stent (LAMS) in benign pathology. Endoscopy. 2026;58(S 03 S 03):S574. doi:10.1055/s-0046-1821719
BibTeX
@article{Urra2026,
author = {Urra, C Pérez and Pinedo, P Espinel and Labrador, C B Bulnes and Ibañez, C Martin and Moretón, ÁM Montero and Castro, E González de and Citores, L Pérez and Antolín, S Maestro and Rodríguez, M A Rizzo and Osa, D Robles de la and Silva, B A Moreira Da and Román, M Cimavilla and Santamarta, F Santos and Fernández, J Santos and Laguna, J Barcenilla and Medina, F J Rancel and Millán, A G Pérez},
title = {Long-term follow-up of Lumen-Apposing Metal Stent (LAMS) in benign pathology},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S574},
doi = {10.1055/s-0046-1821719}
}
EUVIMED